BrainLive Connect: Non-professional Delivered CST for People Living With Dementia
1 other identifier
interventional
520
1 country
1
Brief Summary
The goal of this mixed method study is to evaluate whether the volunteer-led Cognitive Stimulation Therapy (CST) under the BrainLive Connect programme is effective for improving cognitive function and quality of life of people living with dementia (PLwD). The main question it aims to answer are:
- Do PLwD receiving the BrainLive Connect service show better cognitive function and quality of life than those receiving usual care? Researchers will compare BrainLive Connect service to usual care to see whether the intervention leads to better outcomes. Participants will:
- Receive either 7 weeks of BrainLive Connect sessions delivered by trained volunteers or continue receiving usual care.
- Be assessed at baseline (T0), post-intervention (7 weeks; T1), and 1 month follow up (11 weeks; T2).
- Take part in semi-strucutred interviews post-intervention to provide feedback on implementation and areas for improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedStudy Start
First participant enrolled
April 21, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2027
Study Completion
Last participant's last visit for all outcomes
November 10, 2027
April 15, 2026
March 1, 2026
1.6 years
April 8, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)
Possible range: 0 -70, with higher scores indicate more impairment
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
Quality of Life-Alzheimer's Disease (QoL-AD)
Possible range: 13 - 52, with higher scores indicate better quality of life
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
Secondary Outcomes (7)
Neuropsychiatric Inventory Questionnaire (NPIQ)
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
Social functioning in Dementia Scale (HKSF-DEM: carer rating)
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
Care burden (Zarit Burden Interview short version, 12-item)
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
The Lawton Instrumental Activities of Daily Living (IADL)
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
Preference for ageing-in place (self-developed scale)
Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)
- +2 more secondary outcomes
Study Arms (2)
Non-professional delivered CST
EXPERIMENTALParticipants will received 14-session Cognitive Stimulation Therapy (CST) delivered by trained volunteers; two sessions per week; for 7 weeks
Usual social care
ACTIVE COMPARATORParticipants will receive usual social care and support provided by elderly care service units operated by non-governmental organisations, including but not limited to care services, psychosocial intervention, and social activites.
Interventions
CST has been recognized as an effective and cost-effective intervention for individuals with mild to moderate dementia, leading to improvements in cognition and quality of life. CST is one of the few non-pharmacological interventions recommended by the National Institute for Health and Care Excellence (NICE) in their clinical guideline on dementia, as it has comparable efficacy to anti-dementia drugs. Exercise-enhanced CST is characterised by adding physical exercise into the original group CST protocol. Home2Community CST is characterized by a gradual shift of its intervention site from the participant's home to public space in their neighbourhood and then further to centre-based settings. Living CST is characterised by transferring CST into real life settings to maximise its benefits in daily functioning for independent living.
Usual care and support service for people living with dementia in community, including but not limited to, care service, psychosocial intervention (but not CST), and social activities.
Eligibility Criteria
You may qualify if:
- PLwD: Hong Kong residents, mild to moderate dementia, either having i) a formal diagnosis, or 2) suspected dementia reported by care professionals and screened by Montreal Cognitive Assessment (MoCA).
- Family carers: self-identified as the primary carer of the PLwD.
You may not qualify if:
- Unable to communicate and participate in interviews/training/intervention due to hearing impairment, visual impairment, or other conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Simon K.Y.Lee Foundationcollaborator
- Yang Memorial Methodist Social Servicecollaborator
- Christian Family Service Centrecollaborator
- Hong Kong Young Women's Christian Associationcollaborator
Study Sites (1)
The University of Hong Kong
Hong Kong, Hong Kong
Related Publications (7)
Groot C, Hooghiemstra AM, Raijmakers PG, van Berckel BN, Scheltens P, Scherder EJ, van der Flier WM, Ossenkoppele R. The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials. Ageing Res Rev. 2016 Jan;25:13-23. doi: 10.1016/j.arr.2015.11.005. Epub 2015 Nov 28.
PMID: 26607411BACKGROUNDKnapp M, Bauer A, Wittenberg R, Comas-Herrera A, Cyhlarova E, Hu B, Jagger C, Kingston A, Patel A, Spector A, Wessel A, Wong G. What are the current and projected future cost and health-related quality of life implications of scaling up cognitive stimulation therapy? Int J Geriatr Psychiatry. 2022 Jan;37(1). doi: 10.1002/gps.5633. Epub 2021 Oct 15.
PMID: 34613622BACKGROUNDKnapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006 Jun;188:574-80. doi: 10.1192/bjp.bp.105.010561.
PMID: 16738349BACKGROUNDDementia: Assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (NICE); 2018 Jun. Available from http://www.ncbi.nlm.nih.gov/books/NBK513207/
PMID: 30011160BACKGROUNDRyan S, Brady O. Cognitive stimulation and activities of daily living for individuals with mild-to-moderate dementia: A scoping review. Br J Occup Ther. 2023 Aug;86(8):540-559. doi: 10.1177/03080226231156517. Epub 2023 Mar 15.
PMID: 40337614BACKGROUNDToh HM, Ghazali SE, Subramaniam P. The Acceptability and Usefulness of Cognitive Stimulation Therapy for Older Adults with Dementia: A Narrative Review. Int J Alzheimers Dis. 2016;2016:5131570. doi: 10.1155/2016/5131570. Epub 2016 Jul 11.
PMID: 27478677BACKGROUNDDesai R, Leung WG, Fearn C, John A, Stott J, Spector A. Effectiveness of Cognitive Stimulation Therapy (CST) for mild to moderate dementia: A systematic literature review and meta-analysis of randomised control trials using the original CST protocol. Ageing Res Rev. 2024 Jun;97:102312. doi: 10.1016/j.arr.2024.102312. Epub 2024 Apr 16.
PMID: 38636561BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 15, 2026
Study Start (Estimated)
April 21, 2026
Primary Completion (Estimated)
November 10, 2027
Study Completion (Estimated)
November 10, 2027
Last Updated
April 15, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Anonymised data data will be available after the first manuscript using the study data is published.
- Access Criteria
- Anonymised data will be available upon request.
Anonymised data will be available upon request.